Transgenic mice carrying and expressing the human CD3e gene incorporate the corresponding protein product into T cell receptor (TCR)/CD3 complexes on thymocyte and T cell surfaces. The chimeric antigen receptors allow normal T cell development and selection of repertoires in vivo and are able to transduce activation signals in vitro. We have exploited the ability to distinguish mouse (m) and human (h)CD3e chains to analyze the stoichiometry of CD3e in transgenic mouse TCRs. Immunoprecipitation and fluorescence resonance energy transfer experiments demonstrate that such TCRs can contain both h-and mCD3e chains, implying that more than one CD3e subunit occurs per TCR. Antigen comodulation studies are consistent with a stochastic use ofh-or mCD3e during receptor assembly, and further suggest a structure for the TCR/CD3 complex with two CD3e chains. The determination ofCD3e subunit stoichiometry, together with existing biochemical data, allows the generation of a minimal model for the structure of the TCR and illustrates the potential value of the transgenic approach to the analysis of complex receptors.
T
CRs for antigen (TCR/CD3) comprise two types of component: (a) two variable subunits (TCRa/f ory /S) that specifically bind antigen ; and (b) several invariable chains that are noncovalently associated with TCR chains (1, 2) . The invariant chains are implicated in the assembly and regulation of surface expression of the TCR/CD3 complex (3) (4) (5) (6) (7) (8) , as well as in the transduction of antigen-driven activation signals (3, (8) (9) (10) (11) , and consist of the products of the CD3 gene family itself (CD3y, CD3S, CD3e), and the~and 17 chains, which are structurally unrelated to CD3 (12) (13) (14) (15) (16) (17) .
In spite of the rapid progress in our knowledge about the individual subunits, we have limited information about the quaternary structure of the compound receptor. The general view has been that the subunit stoichiometry of TCR/CD3 complex is either oiOybe~2 or ctfyberq (18) (19) (20) . However, we are not aware of any previous study that accurately quantitates the number of individual chains, and therefore, data supporting the above representation of TCR/CD3 subunits are lacking.
It is difficult to establish the stoichiometry of compound receptors in which associations are via noncovalent bonds, as occurs for many of the subunits of the TCR/CD3 complex. We reasoned that one method of calculating the multiplicity of individual subunits might be to study receptors that bear polymorphic forms of a given subunit, which can thus be experimentally distinguished . Transgenic mice facilitate such an approach when the introduced gene is polymorphic with respect to its endogenous counterpart . Here, we have exploited interspecies polymorphism and analyzed CD3e subunit stoichiometry using T cells from human CD3e transgenic mouse strains (21) . We report that both mouse and human CD3e chains can be present in the same TCR/CD3 complex, on T cells that have undergone normal TCR selection in vivo and bear surface receptors that transduce activation signals in vitro, indicating that the TCR contains two CD3e subunits .
Material and Methods
Transgenic Mice. A preliminary description of transgenic mice strains carrying and expressing the human CD3e gene has been published (21) , and further details will be given elsewhere (Olsson, C.; et al., manuscript in preparation) . Briefly, five independent strains were constructed by injection of BDF2 fertilized eggs with Not1-linearized cosmid (cc-1; 13) DNA. The initial backcross of founder mice was with the C57BL/6 inbred strain, and positive hemizygous offspring were subjected to brother/sister mating. Resultant homozygotes were maintained as established transgenic lines from founder mice with low transgene copy numbers (TG16, one copy; TG21, three copies ; TG41, five copies) . High-copy strains (TG22: -40 copies ; TG31 : -90 copies) produced homozygotes infrequently, and in most cases, these mice did not thrive. During the establishment of the TG strains, we observed that 7 of 10 of hemizygous mice carrying high-copy (i .e ., -40 or 90) and 1 of 16 having low-copy (i .e ., one, three, or five) numbers of the transgene had a small spleen and a thymus that was barely detectable. Accordingly, thymocyte numbers were severely reduced to -2 x 10 6/thymus (range, 1-8 x 10 6/thymus), while controls contained 80-100 x 106/thymus. The spleen contained about half the normal T cell numbers . Both thymocytes and spleen T cells in such immunodeficient mice showed significantly reduced levels ofboth mouse (m)'-m and human (h) CDR on the cell surface (our unpublished observations) . Although the immunodeficiency was not strictly related to copy number or transgene integration site, its prevalence in the high-copy mice may be at least partially responsible for our difficulties in establishing viable homozygotes from these lines. The immunodeficient phenotype was not observed in the homozygous transgenic mice, described in this report .
Antibodies. We used mAb specific for either human antigens CD3e (UCHT1; 22) (29) .
Cell Lines, Proliferation, and Cytotoxicity Assays . JM and B6.2.16 BW2 .1 are human and mouse T cell lines, respectively; U937 is an Ig FcR-bearing human histiocytoma . T cell lines from either transgenic and control littermate mouse or human origin were prepared as previously described (21) . The proliferation and "Cr release cytotoxicity assays were performed according to standard methods detailed elsewhere (21, 30) .
Cell Surface Labeling and Itnmunoprecipitation. Approximately 2 x 10' cells of each line were labeled with Na'"I by lactoperoxidase-catalyzed cell surface iodination . Labeled membrane proteins were then extracted under conditions that disrupt (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 2 MM MgCIZ, 2% NP-40, 1 mM PMSF) or preserve (50 mM Tris-HCI, pH 8.0,150 mM NaCl, 2 MM MgCIZ, 1% digitonin, 1 mM PMSF) the noncovalent associations of the TCR/CD3 complex . Lysates were precleared for 30 min at room temperature (RT) with 2 pl ofa mixture of mouse and hamster serum, plus 50 )AI of PBS-washed protein GSepharose (Pharmacia Fine Chemicals, Uppsala, Sweden) . Recovered supernatants were then aliquoted and mAb UCHT1 (100 pl tissue culture supernatant) or 145-2C11 (5 p,l purified antibody), or rodent serum (1 P1) was added followed by 50 p,l protein G-Sepharose (1 h, RT, with gentle rotation) . Sepharose beads were then washed three times at RT in their respective lysis buffers, before boiling in reducing sample buffer and analysis by 10% PAGE.
Immunofuorescence and Fluorescence Resonance Energy Transfer .
The distribution of surface antigens was determined by direct or indirect immunofluorescence, as described elsewhere (30) , using a FACScan analyzer (B-D) . List-mode information from 10' viable cells was accumulated for each analysis. Surface modulation of the TCR/CD3 complex was performed as described by Meuer et al. (31) . We used a FRCS to determine energy transfer between T cell surface molecules bound by FITC-and TRITC-labeled mAb, as described in detail by Szollosi et al. (32) . Briefly, FITC and TRITC were sequentially excited at 488 and 514 rim, respectively. By using suitable filter combinations, we detected FITC and TRITC emissions at 535 min (filter bandpath width of 15 nm) and >590 nm, respectively. Compensation parameters were determined from data obtained using single-labeled cells. Results represent the efficiency 'Abbreviations used in this paper: FRET, fluorescence resonance energy transfer ; h, human; m, mouse; RT, room temperature; TRITC, tetramethylrhodamine isothiocyanate .
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Two CD3e Subunits in the T Cell Receptor of fluorescence resonance energy transfer , where the efficiency of transfer of (nonradiative) energy from donor to acceptor is determined by measuring fluorochrome acceptor emission as well as the quenching of donor fluorescence emission (radiated photons) . The efficiency of transfer is directly related to the average donor-acceptor distance (33) , antigens in higher abundancy being preferred as acceptors (32) (33) (34) .
Results
Analysis of CD3E Subunit Stoichiometry Using Transgenic Mice. We decided to quantitate the number ofCD3E subunits in the TCR/CD3 complex by taking advantage of the unique coexpression of two distinguishable CD3E chains on the T cell surface in hCD3E transgenic mice (21) . Five independent strains of transgenic mice were constructed using a cosmid containing the hCD3E gene and the cis-acting elements required for its appropriate expression. The five strains contained from 1 to 90 copies of the hCD3E gene and were all found to express hCD3E mRNA in the correct T cell-specific fashion as defined by Northern blot assays (Ollson, et al ., manuscript in preparation). T cells derived from independent transgenic strains were submitted to analyses of the subunit associations between the introduced hCD3e and the endogenous TCR/CD3 components . In particular, we asked whether h-and mCD3E subunits occur in the same TCR/CD3 complex by using species-specific anti-CD3E mAb in immunoprecipitation, energy transfer, and surface modulation studies .
Coprecipitation of h-and mCD3E from Transgenic Mouse T Cells. Initially, we carried out immunoprecipitation studies using surface-labeled cells and mAb specific for either hCD3E or mCD3E . 125 1-labeled cells were first lysed using detergent conditions that dissociate TCR heterodimer and CD3 subunits. Under these conditions ( Fig. 1 A) , anti-hCD3E mAb UCHT1 specifically immunoprecipitated a 20-kD polypeptide from T cell lines derived from transgenic mice strains TG16 and TG41 that comigrates with CD3E from the human T cell lineJM. A distinct 25-kD species that comigrates with mCD3e from nontransgenic littermate T cells was immunoprecipitated by anti-mCD3E mAb 145-2C11 from a population of transgenic mouse T cells . Thus, the difference in the molecular weights of h-and mCD3 chains allowed us readily to detect their surface coexpression in the transgenic mouse T cells .
We then analyzed the interaction between the two CD3E subunits and the other endogenous TCR/CD3 components by using aliquots of 125I-labeled cells that were lysed under detergent conditions that preserve TCR/CD3 association . As shown in Fig. 1 B, the endogenous 25-kD mCD3E subunit, as well as the 41-45-kD TCR dimer, were coimmunoprecipitated together with the 20-kD hCD3E by either anti-mCD3E or anti-hCD3E mAb from the surface of transgenic mouse T cells. The specificity of the coprecipitation ofh-and mCD3E was confirmed using human and mouse T cell lines as controls in parallel experiments. A transgene-negative littermate gave very similar results to those of the mouse T cell line (not shown) .
The coprecipitation of h-and mCD3e in the digitonin lysates ( Fig. 1 B) shows that a proportion of TCR/CD3 complexes contains at least two CD3e subunits. The lack ofsuch coprecipitation in the NP40 lysates ( Fig. 1 A) implies that the predominant association of h-and mCD3e is not due to strong, direct e-e interactions .
Fluorescence Resonance Energy Transfer between h-and mCD3e Subunits. We examined further the physical relationship between the human and endogenous CD3e chains by using a different experimental method: flow cytometric analysis and FRET. FRET has been used successfully to determine intraand intermolecular distances at the 2-to 10-nm level in single 9 de la Hera et al . Figure 1 . Coprecipitation o£ h-and mCD3e in T cells from transgenic mice. The indicated human, mouse, or hCD3e transgenic mice T cell lines were surface iodinated and aliquots lysed under conditions that either disrupt (A) or preserve (B) the noncovalent associations of the TCR/CD3 complex . Lysates were submitted to precipitation with antibodies specific for either hCD3e (UCHTI) or mCD3e (145-2C11), or with control rodent sera, followed by 10% PAGE . The autoradiogram was exposed for 48 h . Bold arrows indicate the localization of h-and mCD3e in the gel. The precipitation pattern of the mouse T cell using mAb 145-2C11, specific for mCD3e, shows that, under the conditions used, mCD3y (which has a similar size to hCD3e) is very poorly labeled and is not detected . In the corresponding immunoprecipitation with the mAb specific for human MR, some of the 25-26-kD region may contain mouse CD36 in addition to mouse CD3e .
cells (32) (33) (34) . In our study, we used mAbs against mCD3e and hCD3e that were suitably labeled with either FITC or TRITC . FITC is excited at x+488 nm and can serve as nonradiative energy donor for a nearby (<10-nm distant) TRITC acceptor molecule. The relative spatial distribution of the binding sites for FITC-anti-mCD3e and TRITC-anti-hCD3e was investigated in mouse transgenic T cells. Cells labeled with both conjugated mAb were analyzed to measure the efficiency of energy transfer. The fluorescence distribution found implies energy transfer ( Table 1 ) and indicates that antimCD3e and anti-hCD3e mAbs and their respective binding sites are in close proximity (<10 nm) . The reciprocal donor- acceptor combination, FITC-anti-hCD3e and TRITC-antimCD3e, yielded similar results. The m-and hCD3e-specific pair of mAbs used did not induce energy transfer in nontransgenic T cells.
When similar experiments were carried out using donor/acceptor antibody pairs specific for either h-or mCD3e and mTCR-0, values of efficiency of FRET were in agreement with the hCD3e/mCD3e pair results (Table 1) . This indicates that both the h-and mCD3e chains and the TCR-/3 are in close proximity to each other.
Neither TRITC-anti-CD4 nor TRITC-anti-CD8 mAb, which bind to antigens that are about fourfold more abundant on the T cell surface, acted as acceptors in combination with a FITC-anti-CD3e mAb donor (Table 1) . It is worthy to note that energy transfer between anti-CD4 and anti-CD3 fluorochrome-tagged mAb can take place at 21-37°C after microaggregation of surface molecules, but does not occur at 4°C (34; Table 1 ). This rules our artifactual energy transfer occurring between distant molecules under our working conditions (32) (33) (34) . The FRET results show that the hCD3e-mTCR/CD3 association first detected by immunoprecipitation occurs in all transgenic T cells, and not just in a subpopulation.
Partial comodulation Implies Random Association of h-and mCD3e. The above results imply that the TCR/CD3 complex contains at least two CD3e subunits. IfhCD3e can structurally substitute for mCD3e, the existence of TCR/CD3 complexes containing only either hCD3e or mCD3e subunit pairs should be detectable. We examined this possibility by modulation of the surface expression of either hCD3e or mCD3e subunits and subsequent immunofluorescence and flow cytometry analysis of the reciprocal chain with specific mAb (Fig. 2) . Although anti-mCD3e mAb removed most 10 Two CD3e Subunits in the T Cell Receptor Efficiency (mean percent) (-95%) of surface mCD3e, the expression of hCD3e was only reduced by -60% as compared with modulation with anti-hCD3e mAb. Similarly, anti-hCD3e mAb removed only a portion (ti50%) of mTCR/CD3 complexes in every cell after virtually complete modulation of hCD3e antigen . In contrast, >95% of both hCD3e and mCD3e comodulated with TCR-a/O (Fig. 2) , indicating that both types ofCD3e subunit are integral antigen receptor components. The specificity of the comodulation was confirmed using Thy-1 antigen as control.
These data are consistent with a TCR/CD3 complex that randomly assembles hCD3e and mCD3e subunits within a single receptor, the simplest interpretation being that each complex contains two CD3e chains. Given random usage of either h-or mCD3e in the transgenic mice, a ratio of 1:2:1 of the three species of TCR (comprising m/m-, h/m-, and h/hC133e, respectively) would result . Therefore, since me is represented twice in the me/me TCR/CD3 species, half of the surface mCD3e would be found in he/me-type receptors, and half in me/me complexes, when expressed in molar amounts. In this case, antibodies against hCD3e would be expected to comodulate half of the mCD3e chains from the cell surface, which is close to the experimental result . For hypothetical receptor complexes with three (or more) CD3e chains, HCD3e-specific antibodies should comodulate 75% (or more) ofthe surface mCD3e, which is not observed experimentally. The antigen comodulation data, therefore, strongly suggest a stoichiometry of two CD3e subunits per TCR.
Analysis of T Cell Development in hCD3e Transgenic Mice. We were concerned to demonstrate that the chimeric antigen receptors behaved normally in the transgenic mice, and there- fore, that their function, and hence structure, reflected that found in normal mice. Along these lines, we compared by immunofluorescence and flow cytometry the thymocyte and peripheral lymphoid populations in transgenic and control mice to study the putative effects of transgene expression upon T cell development in vivo. First, we studied the effect of the transgene upon the level of CD3 expression. As shown in Fig. 3 A, subpopulations (49, 35, and 16% , respectively) oftransgenic thymocytes bear either no, low, or high amounts of hCD3e chains, whereas virtually all spleen and lymph node T cells (i.e., mCD3+, Ig -) selectively express high levels of hCD3e (Fig. 3 B) . It is worth noting that, both in the thymus and peripheral lymphoid organs, the transgenic and endogenous CD3e chains were coexpressed in similar amounts on the surface ofevery T cell, each in roughly half ofthe amount of mCD3e found in nontransgenic littermates (Figs. 2 and  3) . Thus, the total (h + m) amount ofCD3e chains expressed in T cells from the transgenic mice approximately equals that found in normal mice.
Second, we studied the association of hCD3e with cx/(3 or y/b types ofTCR. The majority of T cells in the thymus and periphery express TCR ci/(3 associated with hCD3e ( Fig.  2) , whereas the T cells that arise first in ontogeny, occurring in low numbers at day 15 in fetal thymus (25) , instead bear TCR-y/b associated with hCD3e, as found after analysis of fresh thymocytes and confirmed using T cell lines and hybridomas derived from that cell population (Fig. 3 C) . Thus, both T cell lineages express physiological levels of TCR, hCD3e, and mCD3e during ontogeny and in the periphery.
Third, we analyzed the distribution of CD4 and CD8, molecules implicated as TCR/CD3 coreceptors in the processes of positive and negative selection of T cells (35) . The absolute number ofcells found in lymphoid organs, and the proportions of cells in T cell subsets defined by the expression of CD4 and CD8 surface markers, were all within the range found in nontransgenic littermates (Fig. 3 A, B, and D) .
Finally, we monitored the effect upon in vivo selection of TCR repertoires ofthe chimeric TCR/CD3 expressed in the 13 de la Hera et al.
transgenic mice T cells ( (26) . The founder mice for our hCD3e transgenic strains were BDF2, the initial backcross was with B6 mice, and the positive offspring was subsequently subjected to brother/sister mating . Therefore, the homozygous transgenic individual analyzed can either bear or lack expression of I-E gene products depending on the segregation of the MHC haplotype. We found that low frequencies of Vptt-bearing T cells indeed correlate with the expression of I-E in the CDR transgenic mice analyzed ( Table 2 ). The frequencies of T cells bearing either V06 or V08 domains are not significantly modified in the same mice, indicating the specificity of the deletion occurring in the transgenic mice ( Table 2) . We conclude that association of hCD3e with the mouse TCR heterodimer and CD3 complex does not perturb negative selection during T cell development . In summary, after the analysis of >100 individuals from five different transgenic lines from day 14 of fetal age to 1 yr old, it is clear that the surface expression of hCD3e and the subsequent generation of h/m chimeric antigen receptors does not disrupt normal T cell development in our homozygotic transgenic mice. hCD3e-containing TCR/CD3 Complexes Are Functional in Assays In Vitra We also asked whether the presence of hybrid hCD3e-mFCR/CD3 receptors in transgenic T cells affects the function ofTCR/CD3 complex as measured by proliferation and cytotoxicity assays : spleen cells of the transgenic mice showed a strong proliferative response to hCD3e-specific mAb ( Table 3) . The response was similar to that obtained using either mTCR-/3-or mCD3e-specific mAb in spleen cells from both transgenic and nontransgenic mice. We examined whether anti-CD3-stimulated cells expanded in IL-2 mediate TCR/CD3-dependent cytolytic activity (Table 4) . Target cells coated with anti-hCD3e, as well as mCD3e-or OTCRspecific Spleen cells were enriched for T cells using nylon wool columns (21), and 5 x 105 cells in each group were incubated with the indicated biotinconjugated Vg-specific mAb followed by streptavidin-pe and FITC-labeled anti-mCD3. The number of cells stained by Vs-specific mAb is represented as a mean percentage ± SE of total CD3* cells of results obtained for individual mice, with 6-10 mice in each strain analyzed. Similar results were obtained with TG41 strain . The level of expression of I-Ed molecules was measured in unfractionated spleen cells using FITC-conjugated 14 .4 .4 mAb and flow cytometry using an irrelevant CD2-specific mAb as negative control. mAb, but not irrelevant antibodies, were efficiently killed by transgenic T cells. Both the proliferative and cytotoxic responses promoted by anti-hCD3e mAb were specific since they were not detected using nontransgenic T cells. We conclude therefore that the hybrid hCD3e-mTCR/CD3 receptors are functionally competent.
Immunoprecipitation and FRET analyses in T cells from transgenic mice that carry the hCD3e gene have shown that the hCD3e chain is able to replace mCD3e subunits in the assembled TCR/CD3 complex, and that transgenic TCRs can contain both h-and mCD3e. Antigen modulation studies demonstrated that there are two CD3e chains per antigen receptor and defined three receptor species, he/hE, he/ME, and ME/ME, in a ratio of 1:2 :1, respectively, suggesting a stochastic use of human or mouse CD3E during TCR/CD3 assembly. The chimeric antigen receptors support normal T cell development and selection of repertoires in vivo and are 14 Two CD3E Subunits in the T Cell Receptor Table 4 . hCWE-containing Antigen Receptor Complexes Are 5 x 104 mouse spleen or human peripheral blood T cells that had been polyclonally stimulated with anti-CD3 antibodies and cultured for 10 d in the presence of 25 U/ml rll-2 (21) were used as effector cells . They were incubated for 4 h at different E/T ratios with SICr-labeled U937 cells precoated with the indicated antibodies (30) . Results show the mean ± SE 5 'Cr-specific release at 10:1 E/T ratio in one experiment representative of four performed.
able to transduce activation signals in vitro. These findings imply that hCD3e can both structurally and functionally substitute for mCD3e in the transgenic mouse strains studied and show that the TCR/CD3 complex contains two CD3E subunits. Previously, the subunit stoichiometry of the TCR/CD3 complex was considered to be either aaybef2 or aoybc-~,q (18) (19) (20) . However, conclusive data supporting such a representation are lacking. The demonstration that there are two CD3e chains in a functional antigen receptor, together with the data of other workers, allows us to present a minimal model for the TCR/CD3 complex (Fig. 4) . Several biochemical studies of partial receptor complexes have demonstrated four preferential subunit pairs: a/(3, f2, y/E, and 8/E (but not CD3,y/S; [36] [37] [38] , and the model is built up from these pairs. The TCR-a/(3 and f2 dimers can associate with each other in the absence of CD3 (37) , suggesting that the most important structural interaction of f2 is with the TCR heterodimer (Fig. 4) . Chemical crosslinking experiments indicate the proximity of CD3y to TCR-0 (38, 39) and of CD3e to both TCR-a and -0 (38) . This is consistent with a CD3y/e heterodimer lying adjacent to the TCR,3 chain ofthe receptor, and a CD3S/e pair flanking TCR a (Fig. 4) . The model predicts that CD36 contacts TCR-a and not -(3, and further suggests that specificity of contact between CD3 chains and TCR-a or -(3 must reside in the CD3y and -S subunits, since CD3e associates with both chains of the TCR heterodimer. However, such specificity must also allow association of CD3 with TCR-y/S chains. We have shown expression of the human CD3e chain on y/S T cells from E-transgenic mice, and, although we have not investigated the structure of the TCR-y/S/CD3 complex in detail, we feel it is likely that the overall organization will be similar to that of TCR-y/O/CD3 . Considering the demonstration of a functional TCR-S/0/CD3 complex (40), the most parsimonious interpretation would be that TCR-S and -y substitute for TCR a and i(3 chains, respectively, in the TCRy/S/CD3 complex .
The minimal model for the TCR has a stoichiometry of UOy8e2~2. While more complex stoichiometries are conceivable, particularly since at present the minimum representation of chains other than CD3e and -~is not clear, certain of these structures are improbable. For example, a TCR/CD3 complex containing two copies of each CD3 subunit (y2S2e2) is unlikely for the following reasons . Since CD3y/S dimers are not found (36) (37) (38) , a CD3ya82Q complex would have to be grouped as trimers, either ('YSE)2 or , y2E plus Sae . CD3y/S/e subcomplexes have not been documented : although anti-CD3y sera coprecipitate CD3e, they do not detect CD38. Similarly, anti-CD3S sera do not coprecipitate CD3y (38) . Previous immunoprecipitation data suggesting a CD3y/S/E trimer (37, 41) can be seen as the simultaneous precipitation ofy/E and 8/e species by the CD3e-specific antibodies used. Therefore, an antigen receptor with a representation of CD3y2S2E2 would involve the formation ofy2e and See trimers. This would require CD3E to possess duplicated association sites for both CD3y and -S chains, or to bind one subunit of a -y/ ,y (or S/S) dimer. Although possible, these arrangements seem artificially complex compared with the simple y/E and S/E dimers proposed in Fig. 4 , where CD3y and -S associate in a mutually exclusive manner with CD3E, possibly competing for the same binding site on the CD3e protein . This is consistent with the high degree of relatedness of CD3y and -S: one or both of the two conserved sequence motifs found in all CD3y and -S proteins from three species (42) may be involved in association with CD3e. However, additional experiments will be required to provide direct evidence for the stoichiometry of other receptor components and, in particular, to examine the intriguing possibility that the antigen binding subunits could form a tetramer (a202), like Igs, rather than a dimer.
There are a number of consequences of a TCR with two CD3e subunits. (a) The majority of CD3-specific mAbs recognize epitopes conferred by CD3e (21, 43) and therefore have the potential to form strings oflinked TCR/CD3 complexes on the cell surface. This crosslinking function may be the critical mitogenic property of CD3-specific mAbs, since antibodies monovalent for CD3 are nonstimulatory in the absence ofsecondary crosslinking (44) . (b) CD3e-specific mAbs may also crosslink the two CD3e chains within a single TCR, assuming no steric hindrance from other subunits . It is conceivable that inter-receptor and intra-receptor crosslinking might lead to qualitatively or quantitatively different intracellular signals. (c) If a TCR/CD3 complex contains a single a/(3 heterodimer, TCR-a//.3-specific mAbs would have only a limited capacity for receptor crosslinking. This contrasts with CD3e-specific mAbs, and might account for differences in the abilities of the two types ofmAbs to stimulate T cells during T cell selection in thymus organ culture (45) .
Interspecies polymorphism and complementation of TCR/ CD3 subunits allowed the definition of CD3e stoichiometry in transgenic mouse T cells. The transgenic approach to the analysis ofstructure/function relationships ofthe TCR offers several advantages over in vitro systems . It can facilitate the examination of the structure of the receptor: (a) at early developmental stages, where there is limited knowledge of TCR/CD3 subunit expression, assembly, and function ; (b) during negative and positive selection processes; and (c) in the several lineages and subsets derived from T cell precursors, since the different cell populations (or lines) characterized in each strain have the same defined genetic background and do not need to be transformed . Transgenic mice may prove to be of general value as a technique for the analysis of complex receptors.
